GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » PepperLime Health Acquisition Corp (NAS:PEPL) » Definitions » 5-Year EBITDA Growth Rate

PepperLime Health Acquisition (PepperLime Health Acquisition) 5-Year EBITDA Growth Rate : 0.00% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is PepperLime Health Acquisition 5-Year EBITDA Growth Rate?

PepperLime Health Acquisition's EBITDA per Share for the three months ended in Sep. 2023 was $-0.07.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of PepperLime Health Acquisition's 5-Year EBITDA Growth Rate

For the Shell Companies subindustry, PepperLime Health Acquisition's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PepperLime Health Acquisition's 5-Year EBITDA Growth Rate Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, PepperLime Health Acquisition's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where PepperLime Health Acquisition's 5-Year EBITDA Growth Rate falls into.



PepperLime Health Acquisition 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


PepperLime Health Acquisition  (NAS:PEPL) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


PepperLime Health Acquisition 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of PepperLime Health Acquisition's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


PepperLime Health Acquisition (PepperLime Health Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
548 Market Street, Suite 97425, San Francisco, CA, USA, 94104
PepperLime Health Acquisition Corp is a blank check company.
Executives
Kepos Capital Lp 10 percent owner 11 TIMES SQUARE, 35TH FLOOR, NEW YORK NY 10036
Shaolin Capital Management Llc 10 percent owner 230 NW 24TH STREET, SUITE 603, MIAMI FL 33127
Ramzi Haidamus director, officer: Chief Executive Officer C/O IMMERSION CORPORATION, 50 RIO ROBLES, SAN JOSE CA 95134
Eran Pilovsky officer: Chief Financial Officer
Pepperone Llc 10 percent owner 548 MARKET STREET, PMB 97425, SAN FRANCISCO CA 94104
Michelle Fang director 548 MARKET STREET, SUITE 97425, SAN FRANCISCO CA 94104
Britney Blair director 548 MARKET STREET, SUITE 97425, SAN FRANCISCO CA 94104
Frank Ferrari director, officer: President 548 MARKET STREET, SUITE 97425, SAN FRANCISCO CA 94104
Op De Beek Maurice officer: Executive Vice President 548 MARKET STREET, SUITE 97425, SAN FRANCISCO CA 94104

PepperLime Health Acquisition (PepperLime Health Acquisition) Headlines